CNBX Pharmaceuticals Inc. (CNBX) Revenue (2016 - 2024)
CNBX Pharmaceuticals' (CNBX) quarterly Revenue came in at $40637.0 in Q1 2024, down 54.56% on a QoQ basis from $89437.0 in Q4 2023.
CNBX Pharmaceuticals Inc. (CNBX) Revenue (2016 - 2024) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 8 years of Revenue data on file, last reported at $40637.0 in Q1 2024.
- Quarterly Revenue changed N/A year-over-year to $40637.0 in Q1 2024, while the trailing twelve-month figure through Nov 2024 was $40637.0 (down 91.87% YoY) and the FY2024 annual result came in at $130074.0, down 68.29% from the prior year.
- Revenue fell to $40637.0 in Q1 2024, from $89437.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $310165.0 in Q2 2023 to a low of $1310.0 in Q1 2020.
- A 4-year average of $71950.0 and a median of $35297.5 in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2020 — Revenue tumbled 43.53% — and 2023, when it soared 233.8%.
- Tracing CNBX's Revenue over 4 years: stood at $2207.0 in 2020, then soared by 1257.41% to $29958.0 in 2022, then soared by 198.54% to $89437.0 in 2023, then slumped by 54.56% to $40637.0 in 2024.
- The last three Revenue figures came in at $40637.0 (Q1 2024), $89437.0 (Q4 2023), and $100000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 29, 2024 | 40,637.00 |
| Nov 30, 2023 | 89,437.00 |
| Aug 31, 2023 | 100,000.00 |
| May 31, 2023 | 310,165.00 |
| Aug 31, 2022 | 29,958.00 |
| Aug 31, 2020 | 2,207.00 |
| May 31, 2020 | 1,886.00 |
| Feb 29, 2020 | 1,310.00 |
| Nov 30, 2019 | 1,754.00 |
| Aug 31, 2019 | 2,058.00 |
| May 31, 2019 | 2,160.00 |
| Feb 28, 2019 | 2,320.00 |
| Nov 30, 2018 | 3,305.00 |
| Aug 31, 2018 | 2,956.00 |
| May 31, 2018 | 2,956.00 |
| Feb 28, 2018 | 1,931.00 |
| Nov 30, 2017 | 1,758.00 |
| Aug 31, 2017 | 2,870.00 |
| May 31, 2017 | 1,571.00 |
| Feb 28, 2017 | 1,243.00 |